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cAnalysis of Infection Risk Following Covered Stent Exclusion of
Pseudoaneurysms in Prosthetic Arteriovenous Hemodialysis Access
Grafts
Kim CY, Guevara CJ, Engstrom BI, et al. J Vasc Interv Radiol 2012;23:
69-74
Conclusion: Covered stent exclusion of intragraft dialysis access graft
pseudoaneurysms is correlated with a high rate of eventual graft infection.
Summary: Prosthetic arteriovenous (AV) grafts are prone to develop
pseudoaneurysms that are thought related to graft material degeneration
secondary to repeated cannulation at specific sites. Such pseudoaneurysms
may be particularly prone to develop infection in the face of outflow
obstruction. Endovascular treatment can be used to treat prosthetic AV graft
pseudoaneurysms with reports of high technical success and acceptable
patency rates (Vesely TM, J Vasc Interv Radiol 2005;16:1301-7; Najibi S et
al, J Surg Res 2002;106:15-19). However, the authors of this report
indicated an anecdotal impression that incorporating this technique into
their practice resulted in a higher incidence of prosthetic AV graft infection.
They therefore sought to study whether stent graft treatment of prosthetic
AV graft pseudoaneurysms influenced the incidence of AV graft infection.
The authors reviewed their interventional radiology database for prosthetic
AV graft interventions involving stent deployment anywhere within the AV
graft and found 235 interventions in 174 patients between November 2004
and December 2008. The incidence of AV graft infection was analyzed by
stent type (bare metal vs covered), location, and indication for stent deploy-
ment on a per-stent, per-procedure, and per-graft basis. Eventually, 16.3% of
AV grafts with stents implanted required surgical excision for graft infection.
When covered stents were used to treat intragraft pseudoaneurysms, the
subsequent rate of graft infection increased compared with bare-metal stents
or covered stents deployed within the graft for other reasons (42.1% vs
18.2%, P .011). When stents were deployed at an intragraft location, there
was a higher incidence of graft infection compared with those deployed at a
venous anastomosis or in an outflow vein (26.9% vs 6.9%, P  .001).
Comment: Pseudoaneurysms of prosthetic dialysis grafts are usually
associated with a history of repeated punctures at the site where the pseu-
doaneurysm developed. More punctures in a specific site will likely increase
the risk of contamination, and the more the risk of contamination the more
the risk of infection. It follows, as shown here, that placing an additional
prosthetic under such circumstances is not likely to have favorable outcomes.
Cognition After Carotid Endarterectomy or Stenting: A Randomized
Comparison
Altinbas A, van Zandvoort MJ, van den Berg E, et al. Neurology 2011;77:
1084-90.
Conclusion:Despite a substantially higher rate of new ischemic lesions
after carotid artery stenting (CAS) compared with carotid endarterectomy
(CEA), changes in cognition after CAS or CEA are not statically significant.
Summary: Diffusion-weighted (DWI) magnetic resonance imaging
(MRI) shows there is a three times incidence of new ischemic lesions after
CAS compared with CEA (Schnaudigel S et al, Stroke 2008;39:1911-9). In
elderly people, free of dementia and baseline stroke, “silent” infarcts more
than double the risk of dementia and are related to a steeper decline in
cognitive function (Vermeer SE et al, N Engl J Med 2003;348:1215-22).
This study compares effects on cognition of CAS and CEA in patients with
symptomatic carotid artery stenosis. A secondary goal was to compare the
occurrence of new cerebral ischemic lesions on DWI-MRI in CAS and CEA
patients. Patients were derived from two specific participating centers of the
International Carotid Stenting Study (ICSS). Patients in these centers
underwent detailed neuropsychologic examinations before and 6 months
after CEA or CAS revascularization. DWI was performed before the revas-
cularization procedure and 3 days after revascularization. Patients under-
went cognitive testing, and results were standardized into z scores. From this
a cognitive sumscore was calculated. The primary outcome end points were
changes in cognitive sumscores between baseline and follow-up in CAS and
CEA patients. ICSS included 1,713 patients. The two centers that partici-
pated in this study enrolled 177 patients. Of the 177 patients, 140 had a
neuropsychologic examination (NPE) at baseline and 120 had an NPE at
follow-up. CAS was associated with a larger decrease in cognition than
CE,.but between-group differences were not statistically significant (–0.17,
95% confidence interval, –0.38 to 0.03; P  .092). There were 89 patients
who had a pretreatment MRI and 64 who had a MRI 3 days after
revascularization with CAS or CEA. New ischemic lesions were found twice
as often after CAS than after CEA (relative risk, 2.1; 95% confidence interval,
1.0-4.4; P  .041).
o
tComment: The effect on cognition of carotid interventions is coming
nder increased scrutiny, but prospective data are currently very limited.
his study found a very small decline in cognitive function in patients
ndergoing CAS for symptomatic carotid stenosis but not in patients
ndergoing CEA for symptomatic carotid stenosis. It is tempting to relate
his to higher numbers of DWI lesions observed after CAS vs those observed
fter CEA, but no regression analysis was performed, nor is it likely, given the
elatively small number of patients involved vs the small observed effect and
nmeasured confounders such as the location of the infarcts, that a regres-
ion analysis would establish a correlation between number of DWI infarcts
nd postprocedure cognitive decline.
irolimus-Eluting Stents vs. Bare-Metal Stents for Treatment of Focal
esions in Infrapopliteal Arteries: ADouble-Blind,Multi-Centre, Ran-
omized Clinical Trial
astan A, Tepe G, Krankenberg H, et al. Eur Heart J 2011;32:2274-81.
Conclusion: Stent treatment of focal infrapopliteal arterial lesions can
e improved with the use of sirolimus-eluting stents compared with bare-
etal stents.
Summary: Below the knee balloon angioplasty is the mainstay of
ndovascular treatment of infrapopliteal disease. Stents are generally placed
nly after suboptimal results with angioplasty alone. The success of drug-
luting stents for treatment of coronary arteries has led to interest in using
rug eluting stents to treat atherosclerotic lesions in infrapopliteal arteries.
he authors conducted a prospective, randomized, multicenter, double-
lind trial comparing polymer-free sirolimus-eluting stents with a placebo-
oated bare-metal stent in 161 patients with intermittent claudication or
ritical limb ischemia and a primary infrapopliteal atherosclerotic lesion. The
ean target lesion length was 31  9 mm. The main end point was the
-year primary patency rate, defined as freedom from in-stent restenosis
luminal narrowing of 50%) detected with duplex ultrasound imaging or
ith angiography if duplex was nondiagnostic or not technically feasible.
econdary end points included 6-month primary patency rates, secondary
atency rates, and changes in the Rutherford classification system after 1
ear. During follow-up, 25 patients (15.5%) died, and 125 patients reached
he 1-year examination point. Primary patency at 1 year was higher in the
irolimus-eluting stent group (80.6%) than in the bare-metal stent group
55.6%; P .004). Secondary patency rates at 1 year were 91.9% and 71.4%,
espectively (P  .005). Median (interquartile range) change in Rutherford
lassification after 1 year was –2 (–3 to –1) in the sirolimus-eluting stent
roup and –1 (–2 to 0) in the bare-metal stent group (P .004). Event-free
urvival, defined as survival free from target lesions revascularization, major
nd minor amputation, myocardial infarction, and death, was no different
etween the two groups at 12 months (P  .2).
Comment: It does not follow that because drug-eluting stents have
urported advantages in the coronary circulation that they will also be useful
n small peripheral arteries. After all, the coronary and tibial circulations have
ntirely different flow dynamics, and intimal hyperplasia and atherosclerosis
eem to be influenced by patterns of shear stress. Therefore, studies such as
his are necessary to evaluate potential useful translation of technology from
ne vascular bed to another. Determining clinical utility is another matter.
alf the patients in this series were treated for claudication. The very large
ajority of patients with claudication are not going to significantly benefit
rom endovascular treatment of an isolated, short tibial artery stenosis or
cclusion.
Propensity Score-Matched Comparison of Deep vs Mild Hypother-
ia During Thoracoabdominal Aortic Surgery
eiss AJ, Lin H-M, Bischoff MS, et al. J Thorac Cardiovasc Surg 2012;143:
86-93
Conclusion: Deep hypothermic circulatory arrest (DHCA) results in
mproved postoperative adverse outcome rates compared with non-DHCA
echniques in the repair of descending thoracic aortic (DTA) and thoraco-
bdominal aortic aneurysms (TAAA).
Summary: DTAs and TAAAs are often treated with open surgery.
everal adjunctive perfusion techniques are used with open repair of TAAAs
nd DTAs. These include no distal perfusion (clamp and sew), mild hyper-
hermia with atrial-femoral or femoral-femoral bypass, and DHCA. DHCA
or DTA and TAAA repair is, however, largely restricted to high-volume
enters and used selectively. In this study, the authors compared outcomes
f DHCA with non-DHCA techniques for complex repairs of the distal
horacic aorta. They examined the effect of distal ischemic time and temper-
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